GL1X · GenesisL1 explorer

MolNFT v1 · #113536 · protein

NOT4 ring domain in complex with UBC4

5AIE · General negative regulator of transcription subunit 4: “NOT4 ring domain in complex with UBC4”. X-ray diffraction, 1 ligand (ZN), 2 pockets (best druggability 0.42). MolNFT v1 #113536 on GenesisL1: 3D structure, binding sites and…

PDB
5AIE
Type
protein
Length
204 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
General negative regulator of transcription subunit 4; Ubiquitin-conjugating enzyme E2 4
EC
6.3.2.19
UniProt
P34909, P15731
Ligands
ZN
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGeneral negative regulator of transcription subunit 4protein5417% helix, 7% strandP34909
BUbiquitin-conjugating enzyme E2 4 (EC 6.3.2.19)protein15035% helix, 17% strandP15731

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11200.420.7626empty
2560.410.8121empty

Interfaces

1 interface between chains.

  • A–B · 611 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 5AIE · Not4 ring domain in complex with Ubc4 · the same entry in another collection · chain A against A, TM-score 1.00
  • P15731 · AlphaFold monomer V2.0 prediction for ubiquitin-conjugating enzyme E2 4 (P15731) · a predicted model of the same protein · chain B against A, TM-score 0.96
  • P34909 · AlphaFold monomer V2.0 prediction for general negative regulator of transcription subunit… · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.